首页 > 最新文献

Formulary最新文献

英文 中文
FDA approves rolapitant to prevent chemotherapy-induced nausea and vomiting FDA批准诺瑞匹坦预防化疗引起的恶心和呕吐
Formulary
Pub Date : 2016-06-10 DOI: 10.1211/pj.2015.20069288
Daniel S. Raccuia, Pharmd Candidate, L. Holle, Pharmd, Bcop, Fhopa
Rolapitant is a novel NK1 receptor antagonist that maintains >90% receptor binding up to five days after a single 180-mg dose.
罗拉匹坦是一种新型的NK1受体拮抗剂，在单次180毫克剂量后5天内保持>90%的受体结合。
{"title":"FDA approves rolapitant to prevent chemotherapy-induced nausea and vomiting","authors":"Daniel S. Raccuia, Pharmd Candidate, L. Holle, Pharmd, Bcop, Fhopa","doi":"10.1211/pj.2015.20069288","DOIUrl":"https://doi.org/10.1211/pj.2015.20069288","url":null,"abstract":"Rolapitant is a novel NK1 receptor antagonist that maintains >90% receptor binding up to five days after a single 180-mg dose.","PeriodicalId":12354,"journal":{"name":"Formulary","volume":"71 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87077136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
You get what you need 你得到了你需要的
Formulary
Pub Date : 2013-10-15 DOI: 10.2307/j.ctvpj7529.30
PharmD Theodore Hsu
In an open letter to Jim Plagakis, a JP fan decides that even when a paradigm is shattered, there is still value to be had in picking up the pieces.
在一封致吉姆·普拉加基斯的公开信中，一位JP的粉丝认为，即使一个范式被打破了，收拾残片仍然有价值。
{"title":"You get what you need","authors":"PharmD Theodore Hsu","doi":"10.2307/j.ctvpj7529.30","DOIUrl":"https://doi.org/10.2307/j.ctvpj7529.30","url":null,"abstract":"In an open letter to Jim Plagakis, a JP fan decides that even when a paradigm is shattered, there is still value to be had in picking up the pieces.","PeriodicalId":12354,"journal":{"name":"Formulary","volume":"120 7-8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2013-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72448954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
FDA expands Zytiga's use for late-stage prostate cancer FDA扩大Zytiga用于晚期前列腺癌
Formulary
Pub Date : 2012-12-10 DOI: 10.1097/01.cot.0000426461.21453.1c
From Ora Staff Reports
FDA expanded the approved use of abiraterone acetate (Zytiga, Jannsen Bioech) to treat men with late-stage castration-resistant prostate cancer prior to receiving chemotherapy.
FDA扩大了醋酸阿比特龙(Zytiga, Jannsen Bioech)在化疗前治疗晚期去势抵抗性前列腺癌的批准使用范围。
{"title":"FDA expands Zytiga's use for late-stage prostate cancer","authors":"From Ora Staff Reports","doi":"10.1097/01.cot.0000426461.21453.1c","DOIUrl":"https://doi.org/10.1097/01.cot.0000426461.21453.1c","url":null,"abstract":"FDA expanded the approved use of abiraterone acetate (Zytiga, Jannsen Bioech) to treat men with late-stage castration-resistant prostate cancer prior to receiving chemotherapy.","PeriodicalId":12354,"journal":{"name":"Formulary","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2012-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83270367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Eyes to see, ears to hear 眼睛看，耳朵听
Formulary
Pub Date : 2012-07-15 DOI: 10.2307/j.ctt1cgf03m.14
D. Cassell
{"title":"Eyes to see, ears to hear","authors":"D. Cassell","doi":"10.2307/j.ctt1cgf03m.14","DOIUrl":"https://doi.org/10.2307/j.ctt1cgf03m.14","url":null,"abstract":"","PeriodicalId":12354,"journal":{"name":"Formulary","volume":"79 6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2012-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83399077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
This is pharmacy 这是药剂学
Formulary
Pub Date : 2012-06-15 DOI: 10.4324/9781439853078-6
RPh Jim Plagakis
Who says the pharmacist's role has changed over the years? Haven't we always helped patients with their dead sea creatures?
谁说药剂师的角色多年来发生了变化?我们不是一直在帮助病人处理他们死去的海洋生物吗?
{"title":"This is pharmacy","authors":"RPh Jim Plagakis","doi":"10.4324/9781439853078-6","DOIUrl":"https://doi.org/10.4324/9781439853078-6","url":null,"abstract":"Who says the pharmacist's role has changed over the years? Haven't we always helped patients with their dead sea creatures?","PeriodicalId":12354,"journal":{"name":"Formulary","volume":"30 15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2012-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82998196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FDA approves first generic olanzapine to treat schizophrenia, bipolar disorder FDA批准首个奥氮平用于治疗精神分裂症和双相情感障碍
Formulary
Pub Date : 2011-10-25 DOI: 10.1037/e588522012-001
From Ora Staff Reports
FDA has approved the first generic versions of Zyprexa (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder.
FDA已批准再普乐(奥氮平片)和再普乐Zydus(奥氮平口腔崩解片)的首个仿制药用于治疗精神分裂症和双相情感障碍。
{"title":"FDA approves first generic olanzapine to treat schizophrenia, bipolar disorder","authors":"From Ora Staff Reports","doi":"10.1037/e588522012-001","DOIUrl":"https://doi.org/10.1037/e588522012-001","url":null,"abstract":"FDA has approved the first generic versions of Zyprexa (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder.","PeriodicalId":12354,"journal":{"name":"Formulary","volume":"30 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2011-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85510214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bring on the clowns 小丑来了
Formulary
Pub Date : 2009-04-01 DOI: 10.4324/9781315168548-14
Jim Plagakis, Rph
{"title":"Bring on the clowns","authors":"Jim Plagakis, Rph","doi":"10.4324/9781315168548-14","DOIUrl":"https://doi.org/10.4324/9781315168548-14","url":null,"abstract":"","PeriodicalId":12354,"journal":{"name":"Formulary","volume":"50 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2009-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80894039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Caught in the middle 夹在中间
Formulary
Pub Date : 2005-11-21 DOI: 10.12968/sece.2009.2.1447
Carol Ukens
{"title":"Caught in the middle","authors":"Carol Ukens","doi":"10.12968/sece.2009.2.1447","DOIUrl":"https://doi.org/10.12968/sece.2009.2.1447","url":null,"abstract":"","PeriodicalId":12354,"journal":{"name":"Formulary","volume":"190 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2005-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72794906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to create a therapeutics committee that is scientifically and economically sound 如何建立一个在科学上和经济上都合理的治疗委员会
Formulary
Pub Date : 2003-01-01 DOI: 10.3109/9780203996928-1
R. Quintiliani, R. Quercia
One of the primary goals in today's medical environment is to find treatments that provide positive clinical outcomes but also satisfy pressures on healthcare professionals and hospitals to deliver care as cost effectively as possible. To attain this goal, a hospital must have a pharmacy and therapeutics committee that is both scientifically and economically sound. Based on the experience of over 25 years each of the former chaiman of the pharmacy and therapeutics committee (R. Quintiliani) and the director of Drug Information Services (R. Quercia) at Hartford Hospital, a large tertiary hospital in Connecticut, this article addresses ways to acoomplish this goal, with particular attention given to anti-infective agents.
当今医疗环境的主要目标之一是找到既能提供积极的临床结果，又能满足医疗保健专业人员和医院提供尽可能经济有效的护理的压力的治疗方法。为了实现这一目标，医院必须有一个在科学上和经济上都合理的药学和治疗委员会。根据康涅狄格州一家大型三级医院哈特福德医院(Hartford Hospital)前药学和治疗学委员会主席(R. Quintiliani)和药物信息服务主任(R. Quercia) 25年以上的经验，本文探讨了实现这一目标的方法，特别关注抗感染药物。
{"title":"How to create a therapeutics committee that is scientifically and economically sound","authors":"R. Quintiliani, R. Quercia","doi":"10.3109/9780203996928-1","DOIUrl":"https://doi.org/10.3109/9780203996928-1","url":null,"abstract":"One of the primary goals in today's medical environment is to find treatments that provide positive clinical outcomes but also satisfy pressures on healthcare professionals and hospitals to deliver care as cost effectively as possible. To attain this goal, a hospital must have a pharmacy and therapeutics committee that is both scientifically and economically sound. Based on the experience of over 25 years each of the former chaiman of the pharmacy and therapeutics committee (R. Quintiliani) and the director of Drug Information Services (R. Quercia) at Hartford Hospital, a large tertiary hospital in Connecticut, this article addresses ways to acoomplish this goal, with particular attention given to anti-infective agents.","PeriodicalId":12354,"journal":{"name":"Formulary","volume":"21 1","pages":"594-602"},"PeriodicalIF":0.0,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80694191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing and implementing a statewide formulary system: one state's experience. 制定和实施全州配方体系:一个州的经验。
Formulary
Pub Date : 1995-12-01
S J Fiorello

Prior to the Pennsylvania Department of Public Welfare (DPW) implementing a statewide formulary for its 21 mental health hospitals and mental retardation facilities, each facility had its own drug use policy. In many facilities, drugs were ordered with little or no cost-containment or drug-management consideration. To change drug purchasing and usage policies, a task force was created to develop a state formulary system. The task force appointed a formulary subcommittee to research and make recommendations on issues such as drug selections, formulary substitutions, and nonformulary drug use. The step-by-step process of developing and implementing the Pennsylvania DPW state formulary--including pitfalls and successes--is presented.

在宾夕法尼亚州公共福利部(DPW)为其21家精神卫生医院和精神发育迟缓设施实施全州处方之前，每个设施都有自己的药物使用政策。在许多设施中，订购药品时很少或根本没有考虑到成本控制或药物管理。为了改变药品采购和使用政策，成立了一个特别工作组来开发国家处方系统。工作组任命了一个处方小组委员会，就药物选择、处方替代和非处方药物使用等问题进行研究并提出建议。介绍了制定和实施宾夕法尼亚州DPW州公式的逐步过程——包括缺陷和成功。
{"title":"Developing and implementing a statewide formulary system: one state's experience.","authors":"S J Fiorello","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Prior to the Pennsylvania Department of Public Welfare (DPW) implementing a statewide formulary for its 21 mental health hospitals and mental retardation facilities, each facility had its own drug use policy. In many facilities, drugs were ordered with little or no cost-containment or drug-management consideration. To change drug purchasing and usage policies, a task force was created to develop a state formulary system. The task force appointed a formulary subcommittee to research and make recommendations on issues such as drug selections, formulary substitutions, and nonformulary drug use. The step-by-step process of developing and implementing the Pennsylvania DPW state formulary--including pitfalls and successes--is presented.</p>","PeriodicalId":12354,"journal":{"name":"Formulary","volume":"30 12","pages":"808-11"},"PeriodicalIF":0.0,"publicationDate":"1995-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21024359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Formulary
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1